/NSTM
NSTM Stock - NovelStem International Corp.
Healthcare|Medical - Diagnostics & ResearchOTC
$0.02+0.00%
+$0.00 (+0.00%) • Dec 19
52
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.56
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.17
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.02
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NSTM
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.02 – $0.02
TARGET (TP)$0.02
STOP LOSS$0.02
RISK/REWARD1:NaN
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.57
52W High$0.04
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $12,000 | $12,000 | $12,000 | N/A | N/A |
| Gross Profit | $12,000 | $12,000 | $12,000 | N/A | N/A |
| Gross Margin | 100.0% | 100.0% | 100.0% | N/A | N/A |
| Operating Income | $-928,000 | $-3,526,000 | $-422,000 | $-495,535 | $-230,000 |
| Net Income | $-3,233,000 | $-4,187,000 | $-766,000 | $-1,352,453 | $-545,000 |
| Net Margin | -26941.7% | -34891.7% | -6383.3% | N/A | N/A |
| EPS | $-0.07 | $-0.09 | $-0.02 | $-0.03 | $-0.01 |
Company Overview
NovelStem International Corp. focuses on developing and commercialization of diagnostic technology for cancer treatments and the potential to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was founded in 1993 and is headquartered in Boca Raton, Florida.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
NSTMBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q4 2025
EPS Surprise History
Q4 23
No data
Q2 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 18, 2026 | — | — | — | — |
Q4 2025 | Nov 12, 2025 | — | $-0.00 | — | — |
Q3 2025 | Aug 6, 2025 | — | $0.06 | — | — |
Q2 2025 | May 19, 2025 | — | $-0.00 | — | — |
Q2 2025 | Apr 7, 2025 | — | — | — | — |
Q4 2024 | Nov 14, 2024 | — | $-0.05 | — | — |
Q3 2024 | Aug 14, 2024 | — | $-0.01 | — | — |
Q2 2024 | May 15, 2024 | — | $-0.01 | — | — |
Q2 2024 | Apr 1, 2024 | — | $0.00 | — | — |
Q4 2023 | Nov 17, 2023 | — | $-0.02 | — | — |
Q3 2023 | Aug 14, 2023 | — | $-0.06 | — | — |
Q2 2023 | May 12, 2023 | — | $-0.01 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.01 | — | — |
Q4 2022 | Nov 14, 2022 | — | $-0.01 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.00 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.01 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.00 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about NSTM
What is NSTM's current stock price?
NovelStem International Corp. (NSTM) is currently trading at $0.02 per share. The stock has moved +0.00% today.
What is the analyst price target for NSTM?
No analyst price targets are currently available for this stock.
What sector is NovelStem International Corp. in?
NovelStem International Corp. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the OTC exchange.
What is NSTM's market cap?
NovelStem International Corp. has a market capitalization of $0.00 billion, making it a small-cap company.
Does NSTM pay dividends?
No, NovelStem International Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBICTF
Biocure Technology Inc.
$0.01
Mkt Cap: $0.0B
BMCS
BioTech Medics, Inc.
$0.01
Mkt Cap: $0.0B
BMMJ
Body and Mind Inc.
$0.00
Mkt Cap: $0.0B
CHYPF
Health Logic Interactive Inc.
$0.04
Mkt Cap: $0.0B
DTRK
DATATRAK International, Inc.
$0.45
Mkt Cap: $0.0B
EPGNF
Epigenomics AG
$1.12
Mkt Cap: $0.0B
ESMC
Escalon Medical Corp.
$0.17
Mkt Cap: $0.0B
GXXY
Galexxy Holdings, Inc.
$0.01
Mkt Cap: $0.0B
ISCO
International Stem Cell Corporation
$0.14
Mkt Cap: $0.0B
MJNA
Medical Marijuana, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to NSTM for comparison